MCID: CYL004
MIFTS: 31

Cylindromatosis, Familial

Categories: Genetic diseases, Rare diseases, Eye diseases, Skin diseases

Aliases & Classifications for Cylindromatosis, Familial

MalaCards integrated aliases for Cylindromatosis, Familial:

Name: Cylindromatosis, Familial 57 53 25 75 29 13 55 6 40
Ancell-Spiegler Cylindromas 57 25 75 73
Familial Cylindromatosis 53 25 59 37
Turban Tumor Syndrome 53 25 59 75
Dermal Eccrine Cylindroma 53 25
Dermal Eccrine Cylindromatosis 75
Cylindromas, Dermal Eccrine 57
Eccrine Dermal Cylindroma 73
'turban Tumor' Syndrome 57
Turban Tumors 53
Cyld 53
Fcyl 75

Characteristics:

Orphanet epidemiological data:

59
familial cylindromatosis
Inheritance: Autosomal dominant;

OMIM:

57
Inheritance:
autosomal dominant

Miscellaneous:
onset in early adulthood
allelic disorder to multiple familial trichoepithelioma 1 (mft1, ) and brooke-spiegler syndrome (bss, )


HPO:

32
cylindromatosis, familial:
Inheritance autosomal dominant inheritance
Onset and clinical course adult onset


Classifications:



External Ids:

OMIM 57 132700
Orphanet 59 ORPHA211
MESH via Orphanet 45 C536611
UMLS via Orphanet 74 C1704217 C1851526
KEGG 37 H00828

Summaries for Cylindromatosis, Familial

OMIM : 57 The disorders classically referred to as familial cylindromatosis, Brooke-Spiegler syndrome, and multiple familial trichoepithelioma were originally described as distinct clinical entities. Patients with BRSS develop multiple skin appendage tumors including cylindromas, trichoepitheliomas, and spiradenomas. Patients with familial cylindromatosis have only cylindromas, and those with MFT1 have only trichoepitheliomas. However, because these disorders show overlapping phenotypic features, and because different manifestations of each have been described within a single family, many consider these disorders to represent a phenotypic spectrum of a single disease entity (Guggenheim and Schnyder, 1961; Welch et al., 1968; Gerretsen et al., 1995; Lee et al., 2005; Bowen et al., 2005; Young et al., 2006; Saggar et al., 2008). Van Balkom and Hennekam (1994), who preferred the designation 'dermal eccrine cylindromatosis' for familial cylindromatosis, provided a review. 'Eccrine' referred to histologic evidence that the tumors may originate from the eccrine sweat glands. Blake and Toro (2009) provided a detailed review of the spectrum of disorders associated with CYLD mutations. (132700)

MalaCards based summary : Cylindromatosis, Familial, also known as ancell-spiegler cylindromas, is related to brooke-spiegler syndrome and adenoiditis. An important gene associated with Cylindromatosis, Familial is CYLD (CYLD Lysine 63 Deubiquitinase). The drugs Cyclophosphamide and Alkylating Agents have been mentioned in the context of this disorder. Affiliated tissues include skin and eye, and related phenotypes are subcutaneous nodule and telangiectasia of the skin

UniProtKB/Swiss-Prot : 75 Cylindromatosis, familial: A disorder characterized by multiple skin tumors that develop from skin appendages, such as hair follicles and sweat glands. Affected individuals typically develop large numbers of tumors called cylindromas that arise predominantly in hairy parts of the body with approximately 90% on the head and neck. In severely affected individuals, cylindromas may combine into a confluent mass which may ulcerate or become infected (turban tumor syndrome). Individuals with familial cylindromatosis occasionally develop other types of tumors including spiradenomas that begin in sweat glands, and trichoepitheliomas arising from hair follicles.

NIH Rare Diseases : 53 Cylindromas are non-cancerous (benign) tumors that develop from the skin. They most commonly occur on the head and neck and rarely become cancerous (malignant).  An individual can develop one or many cylindromas; if a person develops only one, the cylindroma likely occurred by chance and typically is not inherited. They usually begin to form during mid-adulthood as a slow-growing, rubbery nodule that causes no symptoms. The development of multiple cylindromas can be hereditary and is inherited in an autosomal dominant manner; this condition is called familial cylindromatosis.  Individuals with the inherited form begin to develop many, rounded nodules of various size shortly after puberty. The tumors grow very slowly and increase in number over time.

Genetics Home Reference : 25 Familial cylindromatosis is a condition involving multiple skin tumors that develop from structures associated with the skin (skin appendages), such as hair follicles and sweat glands. People with familial cylindromatosis typically develop large numbers of tumors called cylindromas. While previously thought to derive from sweat glands, cylindromas are now generally believed to begin in hair follicles.

Wikipedia : 76 Cylindromatosis (turban tumor syndrome), also known as CYLD, is a human... more...

Related Diseases for Cylindromatosis, Familial

Diseases related to Cylindromatosis, Familial via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 brooke-spiegler syndrome 11.6
2 adenoiditis 10.2
3 trichoepithelioma, multiple familial, 1 10.1
4 adenoid cystic carcinoma 10.1
5 spiradenoma 10.1
6 nevus, epidermal 9.9
7 sweat gland cancer 9.9
8 hidradenocarcinoma 9.9
9 trichoepithelioma, multiple familial, 2 7.6 CYLD LOC102724907 LOC105371251 MIR3181

Graphical network of the top 20 diseases related to Cylindromatosis, Familial:



Diseases related to Cylindromatosis, Familial

Symptoms & Phenotypes for Cylindromatosis, Familial

Symptoms via clinical synopsis from OMIM:

57
Skin Nails Hair Skin:
cylindromas, multiple (face, trunk and extremities)
cylindromas usually occur on the scalp may coalesce into large 'turban tumors'

Neoplasia:
cylindromas may show malignant transformation

Skin Nails Hair Skin Histology:
mosaic-like masses of epithelial cells surrounded by thin layers of pas-positive stroma
cells appear to be of glandular origin


Clinical features from OMIM:

132700

Human phenotypes related to Cylindromatosis, Familial:

59 32
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 subcutaneous nodule 59 32 hallmark (90%) Very frequent (99-80%) HP:0001482
2 telangiectasia of the skin 59 32 hallmark (90%) Very frequent (99-80%) HP:0100585
3 neoplasm of the skin 32 HP:0008069

Drugs & Therapeutics for Cylindromatosis, Familial

Drugs for Cylindromatosis, Familial (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 7)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 1 50-18-0, 6055-19-2 2907
2 Alkylating Agents Phase 1
3 Antineoplastic Agents, Alkylating Phase 1
4 Antirheumatic Agents Phase 1
5 Imatinib Mesylate Phase 1 220127-57-1 123596
6 Immunosuppressive Agents Phase 1
7 Protein Kinase Inhibitors Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate Completed NCT01046487 Phase 1 Imatinib mesylate, Cyclophosphamide (Dosing level 1 );Imatinib mesylate, Cyclophosphamide (Dosing level 2);Imatinib mesylate, Cyclophosphamide (Dosing level 3)

Search NIH Clinical Center for Cylindromatosis, Familial

Genetic Tests for Cylindromatosis, Familial

Genetic tests related to Cylindromatosis, Familial:

# Genetic test Affiliating Genes
1 Cylindromatosis, Familial 29 CYLD

Anatomical Context for Cylindromatosis, Familial

MalaCards organs/tissues related to Cylindromatosis, Familial:

41
Skin, Eye

Publications for Cylindromatosis, Familial

Articles related to Cylindromatosis, Familial:

# Title Authors Year
1
A new hereditary cylindromatosis family associated with CYLD1 on chromosome 16. ( 10480375 )
1999

Variations for Cylindromatosis, Familial

ClinVar genetic disease variations for Cylindromatosis, Familial:

6
(show top 50) (show all 212)
# Gene Variation Type Significance SNP ID Assembly Location
1 CYLD CYLD, NT2469, G-A, +1 single nucleotide variant Pathogenic
2 CYLD NM_015247.2(CYLD): c.2272C> T (p.Arg758Ter) single nucleotide variant Pathogenic rs121908388 GRCh37 Chromosome 16, 50826538: 50826538
3 CYLD NM_015247.2(CYLD): c.2272C> T (p.Arg758Ter) single nucleotide variant Pathogenic rs121908388 GRCh38 Chromosome 16, 50792627: 50792627
4 CYLD CYLD, 1-BP DEL, 2253G deletion Pathogenic
5 CYLD NM_015247.2(CYLD): c.2806C> T (p.Arg936Ter) single nucleotide variant Pathogenic rs121908390 GRCh37 Chromosome 16, 50830354: 50830354
6 CYLD NM_015247.2(CYLD): c.2806C> T (p.Arg936Ter) single nucleotide variant Pathogenic rs121908390 GRCh38 Chromosome 16, 50796443: 50796443
7 CYLD CYLD, 1-BP DUP, 561T duplication Pathogenic
8 CYLD CYLD, 4-BP DEL, 1950-1GATA deletion Pathogenic
9 CYLD NM_015247.2(CYLD): c.831_834delTGGA (p.Asp277Glufs) deletion Pathogenic rs886040868 GRCh38 Chromosome 16, 50754342: 50754345
10 CYLD NM_015247.2(CYLD): c.831_834delTGGA (p.Asp277Glufs) deletion Pathogenic rs886040868 GRCh37 Chromosome 16, 50788253: 50788256
11 CYLD NM_015247.2(CYLD): c.911dupC (p.Ala305Serfs) duplication Pathogenic rs886040869 GRCh38 Chromosome 16, 50754422: 50754422
12 CYLD NM_015247.2(CYLD): c.911dupC (p.Ala305Serfs) duplication Pathogenic rs886040869 GRCh37 Chromosome 16, 50788333: 50788333
13 CYLD NM_015247.2(CYLD): c.987_988dupAG (p.Gly330Glufs) duplication Pathogenic rs886040871 GRCh38 Chromosome 16, 50776243: 50776244
14 CYLD NM_015247.2(CYLD): c.987_988dupAG (p.Gly330Glufs) duplication Pathogenic rs886040871 GRCh37 Chromosome 16, 50810154: 50810155
15 CYLD NM_015247.2(CYLD): c.1112C> A (p.Ser371Ter) single nucleotide variant Pathogenic rs886040872 GRCh38 Chromosome 16, 50777915: 50777915
16 CYLD NM_015247.2(CYLD): c.1112C> A (p.Ser371Ter) single nucleotide variant Pathogenic rs886040872 GRCh37 Chromosome 16, 50811826: 50811826
17 CYLD NM_015247.2(CYLD): c.1327C> T (p.Gln443Ter) single nucleotide variant Pathogenic rs764952788 GRCh38 Chromosome 16, 50779853: 50779853
18 CYLD NM_015247.2(CYLD): c.1327C> T (p.Gln443Ter) single nucleotide variant Pathogenic rs764952788 GRCh37 Chromosome 16, 50813764: 50813764
19 CYLD NM_015247.2(CYLD): c.1363C> T (p.Gln455Ter) single nucleotide variant Pathogenic rs886040873 GRCh38 Chromosome 16, 50779889: 50779889
20 CYLD NM_015247.2(CYLD): c.1363C> T (p.Gln455Ter) single nucleotide variant Pathogenic rs886040873 GRCh37 Chromosome 16, 50813800: 50813800
21 CYLD NM_015247.2(CYLD): c.1658_1661delATCA (p.Asn553Argfs) deletion Pathogenic rs886040876 GRCh38 Chromosome 16, 50781385: 50781388
22 CYLD NM_015247.2(CYLD): c.1658_1661delATCA (p.Asn553Argfs) deletion Pathogenic rs886040876 GRCh37 Chromosome 16, 50815296: 50815299
23 CYLD NM_015247.2(CYLD): c.1684G> C (p.Ala562Pro) single nucleotide variant Uncertain significance rs886040877 GRCh38 Chromosome 16, 50781411: 50781411
24 CYLD NM_015247.2(CYLD): c.1684G> C (p.Ala562Pro) single nucleotide variant Uncertain significance rs886040877 GRCh37 Chromosome 16, 50815322: 50815322
25 CYLD NM_015247.2(CYLD): c.1684+3A> C single nucleotide variant Uncertain significance rs886040878 GRCh38 Chromosome 16, 50781414: 50781414
26 CYLD NM_015247.2(CYLD): c.1684+3A> C single nucleotide variant Uncertain significance rs886040878 GRCh37 Chromosome 16, 50815325: 50815325
27 CYLD NM_015247.2(CYLD): c.1771A> T (p.Lys591Ter) single nucleotide variant Pathogenic rs886040879 GRCh38 Chromosome 16, 50782411: 50782411
28 CYLD NM_015247.2(CYLD): c.1771A> T (p.Lys591Ter) single nucleotide variant Pathogenic rs886040879 GRCh37 Chromosome 16, 50816322: 50816322
29 CYLD NM_015247.2(CYLD): c.1778G> A (p.Gly593Asp) single nucleotide variant Uncertain significance rs886040880 GRCh38 Chromosome 16, 50782418: 50782418
30 CYLD NM_015247.2(CYLD): c.1778G> A (p.Gly593Asp) single nucleotide variant Uncertain significance rs886040880 GRCh37 Chromosome 16, 50816329: 50816329
31 CYLD NM_015247.2(CYLD): c.1950-2_1953delAGATAT deletion Pathogenic rs886040882 GRCh38 Chromosome 16, 50786853: 50786858
32 CYLD NM_015247.2(CYLD): c.1950-2_1953delAGATAT deletion Pathogenic rs886040882 GRCh37 Chromosome 16, 50820764: 50820769
33 CYLD NM_015247.2(CYLD): c.2041G> C (p.Asp681His) single nucleotide variant Uncertain significance rs886040883 GRCh38 Chromosome 16, 50786946: 50786946
34 CYLD NM_015247.2(CYLD): c.2041G> C (p.Asp681His) single nucleotide variant Uncertain significance rs886040883 GRCh37 Chromosome 16, 50820857: 50820857
35 CYLD NM_015247.2(CYLD): c.2242-2A> G single nucleotide variant Pathogenic rs886040886 GRCh38 Chromosome 16, 50792595: 50792595
36 CYLD NM_015247.2(CYLD): c.2242-2A> G single nucleotide variant Pathogenic rs886040886 GRCh37 Chromosome 16, 50826506: 50826506
37 CYLD NM_015247.2(CYLD): c.2291_2295delAACTA (p.Lys764Ilefs) deletion Pathogenic rs886040887 GRCh38 Chromosome 16, 50792646: 50792650
38 CYLD NM_015247.2(CYLD): c.2291_2295delAACTA (p.Lys764Ilefs) deletion Pathogenic rs886040887 GRCh37 Chromosome 16, 50826557: 50826561
39 CYLD NM_015247.2(CYLD): c.2299A> T (p.Lys767Ter) single nucleotide variant Pathogenic rs886040888 GRCh38 Chromosome 16, 50792654: 50792654
40 CYLD NM_015247.2(CYLD): c.2299A> T (p.Lys767Ter) single nucleotide variant Pathogenic rs886040888 GRCh37 Chromosome 16, 50826565: 50826565
41 CYLD NM_015247.2(CYLD): c.2350+1G> T single nucleotide variant Pathogenic rs886040890 GRCh38 Chromosome 16, 50792706: 50792706
42 CYLD NM_015247.2(CYLD): c.2350+1G> T single nucleotide variant Pathogenic rs886040890 GRCh37 Chromosome 16, 50826617: 50826617
43 CYLD NM_015247.2(CYLD): c.2390_2391delAT (p.Tyr797Terfs) deletion Pathogenic rs886040891 GRCh38 Chromosome 16, 50793585: 50793586
44 CYLD NM_015247.2(CYLD): c.2390_2391delAT (p.Tyr797Terfs) deletion Pathogenic rs886040891 GRCh37 Chromosome 16, 50827496: 50827497
45 CYLD NM_015247.2(CYLD): c.2406_2407delCT (p.Cys802Terfs) deletion Pathogenic rs886040892 GRCh38 Chromosome 16, 50793601: 50793602
46 CYLD NM_015247.2(CYLD): c.2406_2407delCT (p.Cys802Terfs) deletion Pathogenic rs886040892 GRCh37 Chromosome 16, 50827512: 50827513
47 CYLD NM_015247.2(CYLD): c.2515delT (p.Ser839Hisfs) deletion Pathogenic rs886040893 GRCh38 Chromosome 16, 50794257: 50794257
48 CYLD NM_015247.2(CYLD): c.2515delT (p.Ser839Hisfs) deletion Pathogenic rs886040893 GRCh37 Chromosome 16, 50828168: 50828168
49 CYLD NM_015247.2(CYLD): c.2569C> T (p.Gln857Ter) single nucleotide variant Pathogenic rs886040894 GRCh38 Chromosome 16, 50794311: 50794311
50 CYLD NM_015247.2(CYLD): c.2569C> T (p.Gln857Ter) single nucleotide variant Pathogenic rs886040894 GRCh37 Chromosome 16, 50828222: 50828222

Expression for Cylindromatosis, Familial

Search GEO for disease gene expression data for Cylindromatosis, Familial.

Pathways for Cylindromatosis, Familial

GO Terms for Cylindromatosis, Familial

Sources for Cylindromatosis, Familial

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....